Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biosimilars Could Be An Unlikely Boost For Pfizer
Biosimilars Could Be An Unlikely Boost For Pfizer
Biosimilars Could Be An Unlikely Boost For Pfizer
Submitted by
admin
on April 3, 2013 - 10:46am
Source:
Seeking Alpha
News Tags:
biosimilars
Pfizer
trastuzumab
Apixaban
tofacitinib
Headline:
Biosimilars Could Be An Unlikely Boost For Pfizer
Do Not Allow Advertisers to Use My Personal information
